JANE STREET GROUP, LLC - BRIACELL THERAPEUTICS CORP ownership

BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 24 filers reported holding BRIACELL THERAPEUTICS CORP in Q4 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of BRIACELL THERAPEUTICS CORP
ValueSharesWeighting
Q3 2022$546,000
+88.3%
97,092
+93.1%
0.00%
Q2 2022$290,000
-64.5%
50,284
-37.6%
0.00%
Q1 2022$817,000
-62.7%
80,600
-69.6%
0.00%
-100.0%
Q4 2021$2,191,000
+668.8%
264,700
+651.3%
0.00%
Q3 2021$285,00035,2320.00%
Other shareholders
BRIACELL THERAPEUTICS CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Redmond Asset Management, LLC 131,731$508,0000.16%
SABBY MANAGEMENT, LLC 160,182$618,0000.12%
ZEKE CAPITAL ADVISORS, LLC 45,000$174,0000.01%
Freedom Investment Management, Inc. 16,339$63,0000.01%
Virtu Financial LLC 15,121$58,0000.00%
TORONTO DOMINION BANK 12$00.00%
ROYAL BANK OF CANADA 17$00.00%
UBS Group AG 632$2,0000.00%
OSAIC HOLDINGS, INC. 6,012$23,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BRIACELL THERAPEUTICS CORP shareholders